International Conference on Biomedicine & Pharmacotherapy August 06-07, 2018 Osaka, Japan

Dr. Luo is a member of the Divisions of Experimental Pathology, Molecular and Cellular Pathology and Anatomic Molecular Pathology. He is the Director of the High Throughput Genome Center at the Department of Pathology, University of Pittsburgh, involving collaboration of faculties from multiple departments.

Currently, Dr. Luo's research interests involve identifying new tumor suppressor genes and tumor markers in several human malignancies such as prostate cancer, hepatocellular carcinoma, etc. Subsequently, we will direct our effort to evaluate the prognostic values of these genes and markers in making early diagnosis of prostate cancer and serving as drug targets for cancer prevention programs.

Dr. Marion Ben-Jacob has a Ph.D. in theoretical mathematics and is ABD in computer science. She is a Professor in the Department of Mathematics and Computer Sciences at Mercy College for over 36 years. She teaches courses in mathematics and computer science, both in the traditional classroom and online. She has published articles and presented at conferences on the following topics; telemedicine, assessment, mathematics, computer science, computer ethics, pedagogy, online teaching/distance education, collaborative learning, and global learning. She is the editor and a contributing author of Integrating Computer Ethics across the Curriculum. She is the author of an e-book, Computer Ethics: Integrating across the Curriculum

Mathematics and Computer Sciences

Lia Monica Junie is an MD, Ph D, Professor, Head Microbiology Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania. She is a Coordinator of resident doctor’s in the Laboratory Medicine specialty and Leadership PhD doctor’s thesis in Medicine field. She is a Board Member of European professional Societies ESCMID (ESGCP Study Groups), Society of Chemotherapy, Scientia Parasitologica Pro Vita and is a Reviewer of international reviews, Member of International organizations, Director/Coordinator in research projects. She has more than 63 papers published in full in international journals and is an editorial board member of national reviews. She is an Organizer/President, Keynote, Invited Speaker and Chair of International and National Congresses.

Medicine field

41 years professional experience teaching at universities in Poland ( A Mickiewicz University, Jagiellonian University), United States of America (University of Texas at Austin), South Africa (University of Cape Town, University of the Witwatersrand, Johannesburg), Australia (University of Adelaide), Indonesia (Airlangga University, Surabaya) and Switzerland (University of Zurich). Conducted research in Poland, Germany, USA, South Africa, Indonesia, England (University of Oxford), Italy (funded by the National Geographic Society) and Australia (Aboriginal).

human evolution, forensic science, human anatomy, as well as physical anthropology.

Dr. Ernesto Delgado Cidranes MD. PhD is Spanish Anesthesiologist, Director, CEO, Editorial Board Member of Journal Pain Management and Therapy, AIUM Members, Reviewer and Advisor Journal of Ultrasound in Medicine, American Institute (USA), Chairman Department of Anesthesia and Pain Medicine, Spanish University Health Ministry, Professor of advanced ultrasound and Founder at Advanced Pain Management Center Madrid. He has an integrative and interdisciplinary concept in the treatment of pain.

Interventional Pain Management, Pain Treatment

Yahdiana harahap completed her PhD from Pharmacy Department, Faculty of Mathematics and Natural Science, Institute Technology Bandung, Indonesia. She is now the Head of Biavailability and Bioequivalence laboratory Faculty of Pharmacy, Universitas Indonesia. Prior to this position, she was the Dean of Faculty of Pharmacy, Universitas Indonesia. She has published more than 40 papers published in both International and National Journals. She has been an invited speaker in many international conferences, especially in the field of BA/BE and Bioanalysis technique. She currently serves as an expert at Indonesia National Agency of Drug and Food Control, spesifically in BA/BE evaluation.

She currently serves as an expert at Indonesia National Agency of Drug and Food Control, spesifically in BA/BE evaluation.

Mohamed Eddouks is Professor at Moulay Ismail University, Morocco. He is a Researcher in physiology and pharmacology with an M.S. degree in metabolic and molecular endocrinology from the University of Paris 6, France, a specialized certificate in endocrine pharmacology from the University of Paris 7, France, and PhD degrees in physiology and pharmacology from the University of Liege, Belgium, and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his postdoctoral fellowship at the Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 14 years on medicinal plants. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity, and hypertension. His contribution to this field includes three international books and more than 70 peer-reviewed articles and book chapters of international repute. He is member of the editorial boards of 14 international journals. He is also a member of panel of experts of several international journals. He has been the Dean of Polydisciplinary Faculty of Errachidia(2008-2012).

Pharmacology, Ethnopharmacology, Phytotherapy, Pharmacognosy, Phytochemistry, Toxicology, Diabetes, Hypertension, Obesity and Medicinal Plants.

Dr. Kanchan Kohli, M. Pharm, Ph.D (Pharmaceutics) is presently working as an Associate Professor in Dept. of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India with an overall 35 years of teaching experience in under graduation and post graduation courses and research experience. She has completed B. Pharm, M.Pharm, and

Plants have a milieu of phytochemicals that provides protection and treatment of chronic diseases. They are being extensively studied to evaluate their effects for the welfare of public. Much scientific research needs to be conducted before we can begin to make science-based recommendations and launch their formulations in market. Therefore, research is focused on development of novel drug delivery carriers of natural products for their bioavailability enhancement and targeted drug delivery. Other research area includes formulation of conventional dosage forms like tablets and cap

Dr. Xu is a Full Professor in Beijing Normal University-Hong Kong Baptist University United International College (UIC), Zhuhai Scholar Distinguished Professor, Associate Director of UIC Key Lab -Laboratory for Health Promotion Mechanism of Medicinal Food and Folk Remedy, author of 120 peer-reviewed papers. Dr. Xu received Ph.D in Chungnam National University, South Korea. He conducted postdoctoral research work in North Dakota State University, Pur-due University, and Gerald P. Murphy Cancer Foundation during 2005-2009. Dr. Xu is serving as Associate Editor-in-Chief of Food Science and Human Wellness, an Editorial Board member of several international journals. He received inaugural President’s Award for Research of UIC in 2016.

The overall goal of his research is to understand health promoting effects of phytochemicals. Specific interests include: 1) Complex relationship among diet, gut microbiota, and human health, 2) health benefits (targeted at aging, cancers, obesity, and diabetes) assessment of phytochemi-cals from natural products; 3) cellular and molecular mechanisms of bioactive components in dis-ease prevention.

Hanan Hagaris currently working at Zagazig University as an Professor .she has many years’ experience in this field.

Health care

Dr. (Ms) T.Theivasanthi of Kalasalingam University doing research in nanomaterials / nanotechnology; has 15 years of teaching experience; published many research articles/ books and h-index 10; life member of Indian Science Congress Association and Magnetics Society of India; member of International Association of Advanced Materials; serving as Editorial Board Member/ reviewer for some scientific journals; lead editor in JNNN special issue (SAGE Publications, UK); achieved many awards/ honours/ recognitions including - Madurai Women Achievers Award - 2013, Motivational Award - 2015 and 2015 Women’s Day Award of St.Annes College; achieved World Record in LIMCA Book of Records-2015 for nanotechnology invention “World’s first superparamagnetic plants materials” – named “Santhi Particles”, World Record– 2016 for innovative products "The World’s lowest priced graphene" & "World’s Smallest Particles of Vegetables" and World Record– 2017 for the invention "The World’s Smallest Anti-Viral Plant Particles".

nanotechnology

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer.Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

From human vaccines for viral diseases to those ones for oncogenic viruses and tumor antigens

Avi Domb is a Prof. for Medicinal Chemistry and Biomaterials at the Hebrew University of Jerusalem. He earned Bachelor’s degrees in Chemistry, Pharmaceutics and Law; Diplomas in Polymers and Textiles and in Business Administration, and PhD degree in Chemistry from The Hebrew University of Jerusalem. He did his postdoctoral training at Syntex Inc. CA; Harvard Univ. Medical School; MIT, Dept. Chemical Engineering, Cambridge, MA, USA. He was Senior Scientist at the Biological Institute, Ness Ziona, Israel and R&D manager at Nova Pharm. Co. Baltimore USA. Since 1991 he is a faculty member at the Faculty of Medicine, Hebrew University. During 2007-2012 he headed the Division of Forensic Science at the Israel Police and during 2014-2016 he served as President of the Jerusalem College of Engineering (JCE). His current areas of research include: Nanoparticles and nanocoatings, Biopolymers, Drug delivery systems and Forensic Sciences.

Nanoparticles and nanocoatings, Biopolymers, Drug delivery systems and Forensic Sciences